Literature DB >> 26733473

Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.

Erika Leemans1, Kiran V Mahasenan1, Malika Kumarasiri1, Edward Spink1, Derong Ding1, Peter I O'Daniel1, Marc A Boudreau1, Elena Lastochkin1, Sebastian A Testero1, Takao Yamaguchi1, Mijoon Lee1, Dusan Hesek1, Jed F Fisher1, Mayland Chang1, Shahriar Mobashery2.   

Abstract

The oxadiazole antibacterials, a class of newly discovered compounds that are active against Gram-positive bacteria, target bacterial cell-wall biosynthesis by inhibition of a family of essential enzymes, the penicillin-binding proteins. Ligand-based 3D-QSAR analyses by comparative molecular field analysis (CoMFA), comparative molecular shape indices analysis (CoMSIA) and Field-Based 3D-QSAR evaluated a series of 102 members of this class. This series included inactive compounds as well as compounds that were moderately to strongly antibacterial against Staphylococcus aureus. Multiple models were constructed using different types of energy minimization and charge calculations. CoMFA derived contour maps successfully defined favored and disfavored regions of the molecules in terms of steric and electrostatic properties for substitution.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  1,2,4-Oxadiazole; 3D-QSAR; Antibiotic; CoMFA

Mesh:

Substances:

Year:  2015        PMID: 26733473      PMCID: PMC4849414          DOI: 10.1016/j.bmcl.2015.12.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

1.  Beware of q2!

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  J Mol Graph Model       Date:  2002-01       Impact factor: 2.518

2.  Rational selection of training and test sets for the development of validated QSAR models.

Authors:  Alexander Golbraikh; Min Shen; Zhiyan Xiao; Yun-De Xiao; Kuo-Hsiung Lee; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

Review 3.  How to generate reliable and predictive CoMFA models.

Authors:  Lei Zhang; Keng-Chang Tsai; Lupei Du; Hao Fang; Minyong Li; Wenfang Xu
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.

Authors:  Steven L Dixon; Alexander M Smondyrev; Eric H Knoll; Shashidhar N Rao; David E Shaw; Richard A Friesner
Journal:  J Comput Aided Mol Des       Date:  2006-11-24       Impact factor: 3.686

Review 5.  Pushing the boundaries of 3D-QSAR.

Authors:  Richard D Cramer; Bernd Wendt
Journal:  J Comput Aided Mol Des       Date:  2007-01-26       Impact factor: 3.686

6.  Partial charge calculation method affects CoMFA QSAR prediction accuracy.

Authors:  Ruchi R Mittal; Lisa Harris; Ross A McKinnon; Michael J Sorich
Journal:  J Chem Inf Model       Date:  2009-03       Impact factor: 4.956

Review 7.  3D-QSAR in drug design--a review.

Authors:  Jitender Verma; Vijay M Khedkar; Evans C Coutinho
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 8.  Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Int J Antimicrob Agents       Date:  2007-02-16       Impact factor: 5.283

Review 9.  Antibiotics for emerging pathogens.

Authors:  Michael A Fischbach; Christopher T Walsh
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

Review 10.  The evolution of Staphylococcus aureus.

Authors:  Ruud H Deurenberg; Ellen E Stobberingh
Journal:  Infect Genet Evol       Date:  2008-07-29       Impact factor: 3.342

View more
  6 in total

1.  Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials.

Authors:  Yuanyuan Qian; Giuseppe Allegretta; Jeshina Janardhanan; Zhihong Peng; Kiran V Mahasenan; Elena Lastochkin; Melissa Malia N Gozun; Sara Tejera; Valerie A Schroeder; William R Wolter; Rhona Feltzer; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2020-05-08       Impact factor: 7.446

2.  Unconventional Antibacterials and Adjuvants.

Authors:  Mayland Chang; Kiran V Mahasenan; Juan A Hermoso; Shahriar Mobashery
Journal:  Acc Chem Res       Date:  2021-01-29       Impact factor: 22.384

Review 3.  The oxadiazole antibacterials.

Authors:  Jeshina Janardhanan; Mayland Chang; Shahriar Mobashery
Journal:  Curr Opin Microbiol       Date:  2016-05-27       Impact factor: 7.934

4.  3D-QSAR Studies of 1,2,4-Oxadiazole Derivatives as Sortase A Inhibitors.

Authors:  Neda Shakour; Farzin Hadizadeh; Prashant Kesharwani; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2021-12-06       Impact factor: 3.411

5.  Identification of Novel Antibacterials Using Machine Learning Techniques.

Authors:  Yan A Ivanenkov; Alex Zhavoronkov; Renat S Yamidanov; Ilya A Osterman; Petr V Sergiev; Vladimir A Aladinskiy; Anastasia V Aladinskaya; Victor A Terentiev; Mark S Veselov; Andrey A Ayginin; Victor G Kartsev; Dmitry A Skvortsov; Alexey V Chemeris; Alexey Kh Baimiev; Alina A Sofronova; Alexander S Malyshev; Gleb I Filkov; Dmitry S Bezrukov; Bogdan A Zagribelnyy; Evgeny O Putin; Maria M Puchinina; Olga A Dontsova
Journal:  Front Pharmacol       Date:  2019-08-27       Impact factor: 5.810

6.  Isolation of endophytic bacteria from the leaves of Anredera cordifolia CIX1 for metabolites and their biological activities.

Authors:  Celiwe Innocentia Nxumalo; Londeka Sibusisiwe Ngidi; Jabulani Siyabonga Emmanuel Shandu; Tsolanku Sidney Maliehe
Journal:  BMC Complement Med Ther       Date:  2020-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.